Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.

作者: Constance A. Benson , King K. Holmes , Jonathan E. Kaplan , Henry Masur , Alice Pau

DOI:

关键词: Family medicineAlternative medicineMEDLINEMedicinePregnancyGuidelineAdverse effectEpidemiologyDrugHuman immunodeficiency virus (HIV)Gerontology

摘要: The National Institutes of Health, the HIV Medicine Association Infectious Diseases Society America, and CDC have developed guidelines for treatment opportunistic infections (OIs) among adults adolescents infected with human immunodeficiency virus (HIV). These are intended clinicians other health-care providers who care HIV-infected adolescents, including pregnant women; they complement companion OIs children previously published prevention in these populations. They include evidence-based 28 caused by protozoa, bacteria, fungi, viruses, certain endemic parts world but that might be observed patients United States. Each OI section includes information on epidemiology, clinical manifestations, diagnosis, recommendations, monitoring adverse events, management failure, recurrence, special considerations pregnancy. Tables address drugs doses, drug toxicities, interactions, adjustment doses persons reduced renal function, data about use women.

参考文章(632)
C Brechot, F Carnot, H Zylberberg, G Pialoux, S Pol, F Dubois, J Jiang, P Berthelot, F Driss, Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients. Gastroenterologie Clinique Et Biologique. ,vol. 20, pp. 968- 971 ,(1996)
D P Miller, K S Toppenberg, D A Hill, Safety of radiographic imaging during pregnancy. American Family Physician. ,vol. 59, pp. 1813- 1820 ,(1999)
Miller Bw, Holcomb Wl, Howard Tk, Brennan Dc, Goss Ja, Mostello Dj, Renal transplantation one week after conception Transplantation. ,vol. 60, pp. 1353- 1354 ,(1995)
Doreen Matsui, Prevention, diagnosis, and treatment of fetal toxoplasmosis. Clinics in Perinatology. ,vol. 21, pp. 675- 689 ,(1994) , 10.1016/S0095-5108(18)30338-5
A. Lampo, R. Marsboom, P. Vanparys, J. Vandenberghe, R. de Coster, W. Coussement, H. van Cauteren, Safety aspects of oral antifungal agents. The British journal of clinical practice. ,vol. 71, pp. 47- 49 ,(1990)
Thyge L Nielsen, Jan KM Eeftinck Schattenkerk, Birgitte N Jensen, Jens D Lundgren, J Gerstoft, Reindert P Van Steenwijk, Kirsten Bentsen, PH Jos Frissen, Johs Gaub, M Orholm, John-Erik Hansen, Lars Mathiesen, Peter Skinhøj, Sven A Danner, Jens O Nielsen, Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study Journal of Acquired Immune Deficiency Syndromes. ,vol. 5, pp. 726- 731 ,(1992)
Rockenbauer M, Olsen J, Sørensen Ht, Czeizel Ae, A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy. International Journal of Tuberculosis and Lung Disease. ,vol. 5, pp. 564- 568 ,(2001)
ADRIAN M. DI BISCEGLIE, Hepatocellular Carcinoma Annals of Internal Medicine. ,vol. 108, pp. 390- 401 ,(1988) , 10.7326/0003-4819-108-3-390
R. Utili, A. Rambaldi, Marie Françoise Tripodi, A. Andreana, Visceral leishmaniasis during pregnancy treated with meglumine antimoniate. Infection. ,vol. 23, pp. 182- 183 ,(1995) , 10.1007/BF01793862